APA (7th ed.) Citation

Oldenburg, J., Hay, C., Peyvandi, F., Tagliaferri, A., Holme, P. A., Álvarez‐Román, M. T., . . . Repessé, Y. (2025). Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half‐Life FVIII in Hemophilia A: A‐SURE Study. European Journal of Haematology, 114(2), 248. https://doi.org/10.1111/ejh.14309

Chicago Style (17th ed.) Citation

Oldenburg, Johannes, et al. "Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half‐Life FVIII in Hemophilia A: A‐SURE Study." European Journal of Haematology 114, no. 2 (2025): 248. https://doi.org/10.1111/ejh.14309.

MLA (9th ed.) Citation

Oldenburg, Johannes, et al. "Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half‐Life FVIII in Hemophilia A: A‐SURE Study." European Journal of Haematology, vol. 114, no. 2, 2025, p. 248, https://doi.org/10.1111/ejh.14309.